Karen Soares Sells 52,500 Shares of Clover Health Investments, Corp. (NASDAQ:CLOV) Stock

Clover Health Investments, Corp. (NASDAQ:CLOV) General Counsel Karen Soares sold 52,500 shares of Clover Health Investments stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $3.80, for a total transaction of $199,500.00. Following the sale, the general counsel now owns 1,299,663 shares in the company, valued at $4,938,719.40. This represents a 3.88 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Clover Health Investments Trading Down 0.8 %

Shares of CLOV traded down $0.03 during midday trading on Friday, hitting $3.64. The stock had a trading volume of 6,480,128 shares, compared to its average volume of 6,327,543. The business has a 50-day simple moving average of $4.08 and a two-hundred day simple moving average of $3.61. The firm has a market cap of $1.82 billion, a P/E ratio of -18.20 and a beta of 2.00. Clover Health Investments, Corp. has a fifty-two week low of $0.61 and a fifty-two week high of $4.87.

Hedge Funds Weigh In On Clover Health Investments

Large investors have recently made changes to their positions in the business. Vanguard Group Inc. increased its stake in Clover Health Investments by 2.0% in the 4th quarter. Vanguard Group Inc. now owns 19,585,213 shares of the company’s stock valued at $61,693,000 after buying an additional 386,499 shares during the period. Geode Capital Management LLC increased its stake in shares of Clover Health Investments by 1.1% in the fourth quarter. Geode Capital Management LLC now owns 4,882,461 shares of the company’s stock worth $15,387,000 after acquiring an additional 53,760 shares during the last quarter. Marshall Wace LLP raised its holdings in shares of Clover Health Investments by 167.6% during the fourth quarter. Marshall Wace LLP now owns 3,769,765 shares of the company’s stock worth $11,875,000 after acquiring an additional 2,360,902 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its position in Clover Health Investments by 5.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 3,000,505 shares of the company’s stock valued at $8,461,000 after purchasing an additional 150,550 shares during the last quarter. Finally, State Street Corp grew its stake in Clover Health Investments by 65.0% in the third quarter. State Street Corp now owns 2,189,380 shares of the company’s stock valued at $6,174,000 after purchasing an additional 862,621 shares in the last quarter. Institutional investors and hedge funds own 19.77% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Canaccord Genuity Group upped their price objective on Clover Health Investments from $4.20 to $4.50 and gave the company a “buy” rating in a research note on Monday. Craig Hallum started coverage on Clover Health Investments in a research report on Tuesday, December 17th. They set a “buy” rating and a $6.00 price target for the company.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.